Controlled and precise treatment of cardiac tissues

Patent metadata

Field	Value
Publication number	US-12369852-B2
Application number	US-202117501502-A
Country	US
Kind code	B2
Filing date	Oct 14, 2021
Priority date	Oct 21, 2015
Publication date	Jul 29, 2025
Grant date	Jul 29, 2025

Abstract

Systems, devices, and methods for performing precise treatment, mapping, and/or testing of tissues are disclosed. Systems, devices, and methods for administering an agent to one or more a precise regions within a tissue mass are disclosed. Systems, devices, and methods for treating targeted regions within a tissue mass are disclosed. Systems, devices, and methods for identifying, localizing, monitoring neural traffic in the vicinity of, quantifying neural traffic in the vicinity of, and mapping neural traffic near targeted regions within a tissue mass are disclosed.

First claim

What is claimed is:

1. A guidewire comprising:
an elongate body dimensioned for insertion into a lumen within a body; and
one or more sensing tips electrically and mechanically coupled to the elongate body, configured to interface with a wall of the lumen, the one or more sensing tips configured to convey one or more electrophysiologic signals associated with an electrophysiological activity in a vicinity of an anatomical site of interest within a vicinity of the lumen;
a guide tip;
one or more guide rings configured to slidingly engage with the guide tip; and
a floating cage coupled with the one or more guide rings, the floating cage comprising one or more sensing elements of the one or more sensing tips;
wherein the guidewire is configured to monitor the electrophysiological activity.

2. The guidewire in accordance with claim 1 , wherein at least one of the one or more sensing tips comprises a sensor configured to measure one or more electrophysiological signals related to at least one of water concentration, tone, evoked potential, remote stimulation of nervous activity, an electromyographic signal, a mechanomyographic signal, a local field potential, an electroacoustic event, vasodilation, vessel wall stiffness, muscle sympathetic nerve activity, central sympathetic drive, tissue tone, nerve traffic, a smooth muscle action potential, and an extracellular action potential.

3. The guidewire in accordance with claim 1 , wherein at least one of the one or more sensing tips is dimensioned and configured for placement into a cardiac vessel.

4. The guidewire in accordance with claim 1 , further comprising a microcircuit, the microcircuit comprising one or more high fidelity amplifiers and one or more secondary amplifiers each coupled with one or more corresponding sensing tips or secondary sensors.

5. The guidewire in accordance claim 1 , further comprising an analog to digital converter and a digital communication module configured to communicate one or more signals in a digital form along the guidewire during use.

6. The guidewire in accordance with claim 1 , further comprising a microcircuit and at least one of one or more amplifiers and one or more analog to digital converters, the microcircuit being configured to multiplex signals from the one or more sensing elements of the floating cage and said at least one of the one or more amplifiers and the one or more analog to digital converters.

7. The guidewire in accordance with claim 1 , further comprising a reference electrode, at least one of the one or more electrophysiologic signals amplifiable with respect to a potential of the reference electrode.

8. The guidewire in accordance with claim 1 , further comprising a therapeutic delivery module, the therapeutic delivery module being configured to at least one of deliver radiofrequency energy, thermal energy, ultrasound energy, and a substance in the vicinity of the anatomical site of interest.

9. The guidewire in accordance with claim 1 , further comprising a stimulating electrode, the stimulating electrode being configured so as to interface with tissues in the vicinity of the anatomical site of interest.

10. The guidewire in accordance with claim 1 , wherein the guidewire comprises one or more electrodes electrically and mechanically coupled with the elongate body, the one or more electrodes being configured to deliver energy to the anatomical site of interest.

11. The guidewire in accordance with claim 1 , wherein the guidewire comprises one or more microneedles slidingly coupled with the elongate body, the one or more microneedles being configured so as to be deployed beyond the elongate body into the anatomical site of interest.

12. The guidewire in accordance with claim 11 , wherein at least one of the one or more microneedles comprises a lumen through which a substance may be delivered to the anatomical site of interest.

13. The guidewire in accordance with claim 12 , wherein the substance comprises at least one of a neurotoxin, a cancer treating agent, a neuroblocking agent, a neurostimulating agent, a neurodepressant, a vasodilator, a vasoconstrictor, glucose, and insulin.

14. The guidewire in accordance with claim 11 , wherein at least one of the one or more microneedles comprises one or more electrodes for at least one of sensing, stimulating, and ablating the anatomical site of interest.

15. The guidewire in accordance with claim 1 , wherein the floating cage comprises an expandable cage, the expandable cage comprising a plurality of microwires, each microwire of the plurality of microwires being insulated from each other microwire in the plurality of microwires, each microwire in the plurality of microwires having at least one exposed region providing one of the one or more.

16. The guidewire in accordance with claim 1 , further comprising one or more stops coupled to the guide tip, the one or more stops defining a range over which the floating cage may travel.

17. The guidewire in accordance with claim 1 , wherein at least one of the one or more guide rings comprises an electronics housing comprising a microcircuit.

18. The guidewire in accordance with claim 17 , further comprising a bridge electrically and physically coupled to the microcircuit embedded in the electronics housing via a flexible interconnect.

19. The guidewire in accordance with claim 17 , wherein said at least one of the one or more guide rings is electrically coupled to the one or more sensing elements of the floating cage.

20. The apparatus in accordance with claim 17 , wherein movement of the floating cage is limited by a size and positioning of said at least one of the one or more guide rings.

Assignees

• Autonomix Medical Inc

Inventors

• Toth Landy
• Schwartz Robert

Classifications

• A61B5/329

  Load diagnosis, e.g. cardiac stress tests · CPC title

• A61N1/36135

  using physiological parameters · CPC title

• A61B5/352

  Detecting R peaks, e.g. for synchronising diagnostic apparatus; Estimating R-R interval · CPC title

• A61B5/287 Primary

  Holders for multiple electrodes, e.g. electrode catheters for electrophysiological study [EPS] · CPC title

• A61B5/282

  Holders for multiple electrodes (for introduction into the body A61B5/287) · CPC title